Large Cell Neuroendocrine Carcinoma of the Lung

• CLINICAL_TRIALS trial_result · 2026-04-15
  Clinical Trial Update: A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung [Phase 2]

  A Phase 2 single-arm trial evaluating the combination of atezolizumab with platinum-based chemotherapy and etoposide for advanced large-cell…

• CLINICAL_TRIALS trial_result · 2026-03-24
  Clinical Trial Update: DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer [Phase 1]

  Legend Biotech is conducting a Phase 1 trial of DLL3-directed CAR T-cells for extensive-stage small cell lung cancer, with inclusion of larg…

• CLINICAL_TRIALS trial_result · 2024-04-25
  Clinical Trial Update: SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma [Phase 1]

  Phase 1 clinical trial of SNC115 injections for patients with recurrent/refractory small cell lung cancer and large cell neuroendocrine carc…

• CLINICAL_TRIALS trial_result · 2022-03-02
  Clinical Trial Update: Durvalumab (MEDI4736) Plus Platinum-based Chemotherapy in Advanced LCNEC: a Pilot Phase II Study [Phase 2]

  Pilot Phase II study evaluating durvalumab plus platinum-based chemotherapy in advanced LCNEC (large cell neuroendocrine carcinoma) patients…